Posters
« Back
114:Oral Health-related Quality Of Life And Self-reported Anxiety And Depression In Systemic Sclerosis Compared With The UK General Population[AAOM2021]
EP36080
Poster Title: 114:Oral Health-related Quality Of Life And Self-reported Anxiety And Depression In Systemic Sclerosis Compared With The UK General Population[AAOM2021]
Submitted on 29 Mar 2021
Author(s): Ismail Abdouh1,2, Stephen Porter1, Stefano Fedele1,3, Nadia Elgendy4, Khalid Aboalshamat5, Hamzah Babkair2, Richeal Ni Riordain1,6
Affiliations: 1: Oral Medicine, UCL Eastman Dental Institute, London, United Kingdom; 2: Department of Oral Basic and Clinical Sciences, College of Dentistry, Taibah University, Al Madinah Al Munawarah, Kingdom of Saudi Arabia; 3: Oral theme UCLH/UCL NIHR, Biomedical Research Centre, London, United Kingdom; 4: Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia; 5: Dental Public Health Division, Preventative Dentistry Department, College of Dentistry, Umm Al-Qura University, Makkah, Saudi Arabia; 6: University College Cork, Cork, Ireland
This poster was presented at 2021 American Academy of Oral Medicine Virtual Conference
Poster Views: 315
View poster »


Poster Information
Abstract: Objectives: The objective of the present study was to identify the impact of systemic sclerosis (SSc) upon oral health-related quality of life (OHRQoL) of affected individuals resident in the UK.

Methods: This study comprised 50 patients with SSc and 18 partners or carers who acted as controls. All respondents were invited to complete questionnaires regarding the impact of SSc on quality of life and psychological wellbeing using valid and reliable patient-reported outcome measures (OHIP-14, MHISS, OIDP, MDAS and HADS). Statistical analyses were performed for comparisons of different variables.

Results: All the mean scores of OHIP-14 [SSc (16.5±12.4) Vs controls (6.06±7.6, P .001)], MHISS components were significantly higher in patients than those of control group [SSc (21.26±12) Vs controls (4.8±7.3, P<.0001)]. Majority of OIDP mean scores were significantly worse in patients compared with controls [SSc (10±8.7) Vs controls (1.72±3.4, P<.0001)]. The mean of total MDAS [SSc (11.7±5.3) Vs controls (9.5±4.4)] and HADS scores were higher in patients compared to controls [SSc depression (4.8±3.3) and anxiety (6±4.6) Vs controls (3.7±3.1) (4.7±3.9)].

Conclusions: Systemic sclerosis has a negative impact on OHRQoL of the affected individuals. Administration of both generic and specific quality of life measures may provide a means of evaluating disease co-morbidity.
Summary: The objective of the present study was to identify the impact of systemic sclerosis (SSc) upon oral health-related quality of life (OHRQoL) of affected individuals resident in the UK.

Ask the author questions about this poster:drabdouh@hotmail.com
References: • KWAKKENBOS, L., DELISLE, V. C. 2015. Psychosocial Aspects of Scleroderma. Rheum Dis Clin North Am, 41, 519-28
• JUNG, S., MARTIN, T., SCHMITTBUHL, M. & HUCK, O. 2016. The spectrum of orofacial manifestations in systemic sclerosis: a challenging management. Oral Dis.
• INGEGNOLI, F., UGHI, N. & MIHAI, C. 2018. Update on the epidemiology, risk factors, and disease outcomes of systemic
sclerosis. Best Pract Res Clin Rheumatol, 32, 223-240.
•BARON,M.,HUDSON,M.2014.TheCanadiansystemicsclerosisoralhealthstudy:orofacial manifestations and oral health related quality of life in systemic sclerosis compared with the general population. Rheumatology(Oxford),53,1386-94.
• SMIRANI, R., TRUCHETET, M. E., POURSAC, N., NAVEAU, A., SCHAEVERBEKE, T. & DEVILLARD, R. 2018. Impact of systemic sclerosis oral manifestations on patients' health-related quality of life: A systematic review. J Oral Pathol Med, 47, 808-815.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons